SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 34 filers reported holding SINOVAC BIOTECH LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $6,243,000 | +12.6% | 1,091,500 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $5,545,000 | -3.2% | 1,091,500 | 0.0% | 0.02% | +5.6% |
| Q2 2015 | $5,730,000 | +5.8% | 1,091,500 | 0.0% | 0.02% | +5.9% |
| Q1 2015 | $5,414,000 | -2.8% | 1,091,500 | +2.5% | 0.02% | -10.5% |
| Q4 2014 | $5,572,000 | +22.0% | 1,065,301 | +12.2% | 0.02% | +5.6% |
| Q3 2014 | $4,566,000 | -14.7% | 949,300 | 0.0% | 0.02% | -10.0% |
| Q2 2014 | $5,354,000 | -30.5% | 949,300 | -11.2% | 0.02% | -28.6% |
| Q1 2014 | $7,700,000 | +17.6% | 1,069,500 | 0.0% | 0.03% | +7.7% |
| Q4 2013 | $6,545,000 | +2.3% | 1,069,500 | 0.0% | 0.03% | -16.1% |
| Q3 2013 | $6,396,000 | +52.2% | 1,069,500 | 0.0% | 0.03% | +29.2% |
| Q2 2013 | $4,203,000 | – | 1,069,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verity Asset Management, Inc. | 35,884 | $188,000 | 0.17% |
| Orbimed Advisors | 2,667,500 | $14,004,000 | 0.10% |
| Freedom Investment Management, Inc. | 157,295 | $826,000 | 0.08% |
| Pine River Capital Management L.P. | 1,095,041 | $5,749,000 | 0.06% |
| FIRST MANHATTAN CO. LLC. | 603,666 | $3,169,000 | 0.02% |
| FIL Ltd | 1,091,500 | $5,730,000 | 0.02% |
| Renaissance Technologies | 1,263,200 | $6,632,000 | 0.02% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 179,899 | $944,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 4,068,406 | $21,359,000 | 0.01% |
| ProShare Advisors LLC | 44,592 | $234,000 | 0.00% |